✦ LIBER ✦

Optimizing Suicide Gene Therapy for Head and Neck Cancer

✍ Scribed by Duane A. Sewell; Daqing Li; Ling Duan; Mary R. Schwartz; Bert W. O'Malley Jr

Book ID: 110079505
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 728 KB
Volume: 107
Category: Article
ISSN: 0023-852X
DOI: 10.1097/00005537-199711000-00012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy for head and neck cancer

✍ Dr. Gary L. Clayman 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

Background. Molecular or gene therapy involves the introduction of genetic material (DNA) into host cells to induce the expression of the therapeutic product of that gene. This ability to transfer genetic material provides a novel approach for the investigation and potential treatment of a variety o

Combination Nonviral Cytokine Gene Thera

Combination Nonviral Cytokine Gene Therapy for Head and Neck Cancer

✍ Daqing Li; Jacob W. Zeiders; Shixi Liu; Ming Guo; Yun Xu; Jeffrey S. Bishop; Ber 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

DNA therapy for head and neck cancer

✍ Aujla, Mandy 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 48 KB

Radiation therapy for head and neck canc

Radiation therapy for head and neck cancers

✍ C. C. Wang 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 2 views

Proton radiation therapy for head and ne

Proton radiation therapy for head and neck cancer

✍ Annie W. Chan; Norbert J. Liebsch 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract Due to the close spatial relationship of head and neck and skull base tumors to numerous normal anatomical structures, conventional photon radiation therapy can be associated with significant acute and long‐term treatment‐related toxicities. Superior dose localization properties of prot

Alloantigen gene therapy for head and ne

Alloantigen gene therapy for head and neck cancer: Evaluation of animal models

✍ Lyon L. Gleich; Ya-Qin Li; Shunan Li; Jack L. Gluckman; Peter J. Stambrook 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Background: Human trials of alloantigen gene therapy, using the class i major histocompatibility complex (mhc) hla-b7, have demonstrated the potential efficacy of this treatment for head and neck cancer. its mechanism remains unclear. an immune-competent mouse model of mhc gene therapy to test f